80 related articles for article (PubMed ID: 20433421)
1. Oct-4B isoform is differentially expressed in breast cancer cells: hypermethylation of regulatory elements of Oct-4A suggests an alternative promoter and transcriptional start site for Oct-4B transcription.
Wang Y; Meng L; Hu H; Zhang Y; Zhao C; Li Q; Shi F; Wang X; Lin A
Biosci Rep; 2011 Apr; 31(2):109-15. PubMed ID: 20433421
[TBL] [Abstract][Full Text] [Related]
2. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
[TBL] [Abstract][Full Text] [Related]
3. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T
Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847
[TBL] [Abstract][Full Text] [Related]
4. Abnormal DNA methylation of the Oct-4 enhancer region in cloned mouse embryos.
Kawasumi M; Unno Y; Matsuoka T; Nishiwaki M; Anzai M; Amano T; Mitani T; Kato H; Saeki K; Hosoi Y; Iritani A; Kishigami S; Matsumoto K
Mol Reprod Dev; 2009 Apr; 76(4):342-50. PubMed ID: 18932201
[TBL] [Abstract][Full Text] [Related]
5. Genomic organization and regulation of the human orexin (hypocretin) receptor 2 gene: identification of alternative promoters.
Chen J; Randeva HS
Biochem J; 2010 Apr; 427(3):377-90. PubMed ID: 20156195
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the Oct-3/4 gene in cell culture model systems that parallel different stages of mammalian development.
Mallanna SK; Boer B; Desler M; Rizzino A
Mol Reprod Dev; 2008 Aug; 75(8):1247-57. PubMed ID: 18213644
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor accessibility and histone acetylation of the progesterone receptor gene differs between parental MCF-7 cells and a subline that has lost progesterone receptor expression.
Xu X; Murdoch FE; Curran EM; Welshons WV; Fritsch MK
Gene; 2004 Mar; 328():143-51. PubMed ID: 15019994
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of the murine Elf3 gene in embryonal carcinoma cells and their differentiated counterparts: requirement for a novel upstream regulatory region.
Hou J; Wilder PJ; Bernadt CT; Boer B; Neve RM; Rizzino A
Gene; 2004 Sep; 340(1):123-31. PubMed ID: 15556300
[TBL] [Abstract][Full Text] [Related]
10. PEA3, AP-1, and a unique repetitive sequence all are involved in transcriptional regulation of the breast cancer-associated gene, mammaglobin.
Hesselbrock DR; Kurpios N; Hassell JA; Watson MA; Fleming TP
Breast Cancer Res Treat; 2005 Feb; 89(3):289-96. PubMed ID: 15754128
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of human, bovine, and murine Oct-4 upstream promoter sequences.
Nordhoff V; Hübner K; Bauer A; Orlova I; Malapetsa A; Schöler HR
Mamm Genome; 2001 Apr; 12(4):309-17. PubMed ID: 11309664
[TBL] [Abstract][Full Text] [Related]
12. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
13. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
Ai L; Tao Q; Zhong S; Fields CR; Kim WJ; Lee MW; Cui Y; Brown KD; Robertson KD
Carcinogenesis; 2006 Jul; 27(7):1341-8. PubMed ID: 16501252
[TBL] [Abstract][Full Text] [Related]
15. Functional elements demarcated by histone modifications in breast cancer cells.
Choe MK; Hong CP; Park J; Seo SH; Roh TY
Biochem Biophys Res Commun; 2012 Feb; 418(3):475-82. PubMed ID: 22285863
[TBL] [Abstract][Full Text] [Related]
16. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
Zhao C; Lam EW; Sunters A; Enmark E; De Bella MT; Coombes RC; Gustafsson JA; Dahlman-Wright K
Oncogene; 2003 Oct; 22(48):7600-6. PubMed ID: 14576822
[TBL] [Abstract][Full Text] [Related]
17. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
19. Identification of DPPA4 and other genes as putative Sox2:Oct-3/4 target genes using a combination of in silico analysis and transcription-based assays.
Chakravarthy H; Boer B; Desler M; Mallanna SK; McKeithan TW; Rizzino A
J Cell Physiol; 2008 Sep; 216(3):651-62. PubMed ID: 18366076
[TBL] [Abstract][Full Text] [Related]
20. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
Lin X; Nelson WG
Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
